EDGAR Filing Documents for 0001171843-15-001105

Form 8-K - Current report:

SEC Accession No. 0001171843-15-001105

Filing Date

2015-02-26

Accepted

2015-02-26 16:44:49

Documents

Period of Report

2015-02-24

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_022615.htm	8-K	36612
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	7309
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	78467
	Complete submission text file	0001171843-15-001105.txt		123701

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15653216
SIC: 2834 Pharmaceutical Preparations